Edward Nash
Stock Analyst at Canaccord Genuity
(4.90)
# 281
Out of 5,090 analysts
398
Total ratings
49.7%
Success rate
25.6%
Average return
Main Sectors:
Stocks Rated by Edward Nash
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Reiterated: Buy | $10 → $13 | $3.97 | +227.46% | 2 | Oct 30, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $129 | $126.63 | +1.87% | 6 | Oct 30, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $106 → $118 | $27.28 | +332.55% | 14 | Oct 30, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Buy | $612 | $430.36 | +42.21% | 43 | Oct 29, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $98 | $92.24 | +6.24% | 7 | Oct 28, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $13.96 | $1.62 | +762.01% | 29 | Oct 28, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $70 | $50.39 | +38.92% | 42 | Oct 28, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $161 | $81.12 | +98.47% | 58 | Oct 27, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $50 → $60 | $45.08 | +33.10% | 3 | Oct 13, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $6 | $0.8022 | +647.94% | 6 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $9.92 | +464.52% | 13 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $3.65 | +475.34% | 15 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $38.87 | +293.62% | 4 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $30.10 | +99.34% | 14 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 | $21.87 | +407.54% | 4 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.59 | +747.46% | 20 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.8589 | +249.28% | 16 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $2.19 | +1,041.55% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.95 | n/a | 8 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.11 | n/a | 6 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $1 | $0.0001 | n/a | 2 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.59 | n/a | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $1.66 | n/a | 1 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $39 | $3.59 | n/a | 9 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $18.62 | n/a | 15 | Feb 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $64 | $24.83 | n/a | 2 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $117 | $58.51 | n/a | 14 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $71 | $16.10 | n/a | 11 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $156 | $48.28 | n/a | 1 | Sep 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $132 | $892.87 | n/a | 1 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $4 | $16.03 | n/a | 3 | Jun 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $13.45 | n/a | 1 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $23 | $4.35 | n/a | 2 | May 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.0001 | n/a | 1 | Sep 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $2 | $0.0001 | n/a | 2 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $6 | $2.47 | n/a | 8 | May 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $7.51 | n/a | 3 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $3.50 | n/a | 3 | Sep 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.116 | n/a | 1 | Jun 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $14.04 | n/a | 2 | May 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.59 | n/a | 1 | Jan 28, 2013 |
Aclaris Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $3.97
Upside: +227.46%
Kymera Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $129
Current: $126.63
Upside: +1.87%
Viking Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $106 → $118
Current: $27.28
Upside: +332.55%
Madrigal Pharmaceuticals
Oct 29, 2026
Reiterated: Buy
Price Target: $612
Current: $430.36
Upside: +42.21%
Kiniksa Pharmaceuticals International,
Oct 28, 2026
Reiterated: Buy
Price Target: $98
Current: $92.24
Upside: +6.24%
Cardiol Therapeutics Inc.
Oct 28, 2026
Reiterated: Buy
Price Target: $13.96
Current: $1.62
Upside: +762.01%
Travere Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $70
Current: $50.39
Upside: +38.92%
Corcept Therapeutics
Oct 27, 2026
Reiterated: Buy
Price Target: $161
Current: $81.12
Upside: +98.47%
First Tracks Biotherapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $45.08
Upside: +33.10%
Connect Biopharma Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $6
Current: $0.8022
Upside: +647.94%
Oct 1, 2026
Reiterated: Buy
Price Target: $56
Current: $9.92
Upside: +464.52%
Sep 29, 2026
Reiterated: Buy
Price Target: $20 → $21
Current: $3.65
Upside: +475.34%
Sep 28, 2026
Reiterated: Buy
Price Target: $153
Current: $38.87
Upside: +293.62%
Sep 23, 2026
Reiterated: Buy
Price Target: $60
Current: $30.10
Upside: +99.34%
Sep 9, 2026
Reiterated: Buy
Price Target: $111
Current: $21.87
Upside: +407.54%
Aug 17, 2026
Reiterated: Buy
Price Target: $5
Current: $0.59
Upside: +747.46%
Aug 13, 2026
Reiterated: Hold
Price Target: $3
Current: $0.8589
Upside: +249.28%
May 14, 2026
Rated: Buy
Price Target: $25
Current: $2.19
Upside: +1,041.55%
Oct 2, 2024
Reiterated: Buy
Price Target: $9
Current: $3.95
Upside: n/a
May 17, 2023
Reiterated: Hold
Price Target: $2
Current: $4.11
Upside: n/a
Jul 29, 2022
Downgraded: Hold
Price Target: $12 → $1
Current: $0.0001
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $25
Current: $8.59
Upside: n/a
Jun 5, 2019
Downgraded: Hold
Price Target: $5
Current: $1.66
Upside: n/a
May 20, 2019
Reiterated: Buy
Price Target: $60 → $39
Current: $3.59
Upside: n/a
Feb 27, 2019
Reiterated: Buy
Price Target: $176
Current: $18.62
Upside: n/a
Feb 26, 2019
Reiterated: Buy
Price Target: $48 → $64
Current: $24.83
Upside: n/a
Feb 25, 2019
Reiterated: Buy
Price Target: $126 → $117
Current: $58.51
Upside: n/a
Jan 23, 2019
Reiterated: Buy
Price Target: $54 → $71
Current: $16.10
Upside: n/a
Sep 24, 2018
Reiterated: Buy
Price Target: $156
Current: $48.28
Upside: n/a
Sep 17, 2018
Reiterated: Buy
Price Target: $132
Current: $892.87
Upside: n/a
Jun 27, 2018
Downgraded: Hold
Price Target: $22 → $4
Current: $16.03
Upside: n/a
Jun 25, 2018
Initiated Coverage: Buy
Price Target: $26
Current: $13.45
Upside: n/a
May 16, 2018
Reiterated: Buy
Price Target: $26 → $23
Current: $4.35
Upside: n/a
Sep 18, 2017
Reiterated: Buy
Price Target: $24
Current: $0.0001
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $1 → $2
Current: $0.0001
Upside: n/a
May 5, 2017
Reiterated: Hold
Price Target: $3 → $6
Current: $2.47
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $9
Current: $7.51
Upside: n/a
Sep 4, 2014
Downgraded: Hold
Price Target: $14 → $11
Current: $3.50
Upside: n/a
Jun 17, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $0.116
Upside: n/a
May 3, 2013
Downgraded: Sell
Price Target: n/a
Current: $14.04
Upside: n/a
Jan 28, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $20.59
Upside: n/a